Community and mobile phone program for high blood pressure control in Nepal
Tests a community and phone program to help adults with high blood pressure.
Plain-language title generated from the registry record
Registry title: Community-and Primary Care-based Intervention Linked With mObile Technology for HTN Control in Nepal
Key facts
- Where
- Namobuddha, NepalSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 30 and 70 years old?
Source: NCT07076134, who can take part
Where in Nepal
- Namobuddha municipalityNamobuddha, NepalNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Duke Kunshan University
- Trial code
- NCT07076134
- Record updated
- 17 August 2025
- Original description
The clinical trial aims to evaluate whether a community and primary care-based intervention linked with mobile technology (CoPILOT) is acceptable, effective, cost-effective, sustainable, and scalable in improving hypertension (HTN) control among individuals aged 30 to 70 in Nepal. The primary research questions include:Read full original descriptionShow less
A Pilot Trial of a Community-and Primary Care-based Intervention Linked With mObile Technology for Hypertension Control in Nepal (CoPILOT Trial)
The clinical trial aims to evaluate whether a community and primary care-based intervention linked with mobile technology (CoPILOT) is acceptable, effective, cost-effective, sustainable, and scalable in improving hypertension (HTN) control among individuals aged 30 to 70 in Nepal. The primary research questions include:
Is the use of the application by Frontline Health Workers (FLHWs) and Female Community Health Volunteers (FCHVs) feasible and acceptable? Can FCHVs equipped with mHealth technology effectively increase the linkage of individuals with elevated blood pressure (BP) to health facilities? Does a mobile-based lifestyle intervention reduce or control BP? Can adherence to prescribed HTN treatments be improved among patients through this intervention?
Inclusion: Hypertensive patient's should be in the range of 30 to 70 years old living in selected communities with HTN (systolic BP ≥ 130 mmHg or diastolic ≥ 85 mmHg or taking antihypertensive medication); They should have been diagnosed previously and under medication; They should agree to the informed consent; FCHVs should be working for the selected communities and agree to the informed consent; FLHWs should work for the health facilities in selected communities and agree to the informed consent.
Exclusion: Participants who are not able to respond during the data collection period; Participants who are out of municipality during the data collection period.